Botulinum Neurotoxin Compositions Using NAPs for Extended Effects

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current botulinum neurotoxin compositions face limitations in efficacy and duration of effect, necessitating higher dosages and more frequent administrations for cosmetic and therapeutic applications.

Innovation Solution

The compositions include augmented amounts of neurotoxin-associated proteins (NAPs) and/or vasoconstrictors, such as Hn-33 and epinephrine, to enhance the efficacy and duration of effect by increasing the uptake of the neurotoxin into cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If standard botulinum neurotoxin compositions are used, then the basic neurotoxic effect is achieved, but the duration of effect is limited requiring higher dosages and more frequent administrations

Engineering Contradiction:
Improveduration of effectVSAvoiddosage frequency
Core Design Contradiction:
Duration of action of moving objectVSQuantity of substance

Solution Approach 1:

The patent combines botulinum neurotoxin with neurotoxin-associated proteins (NAPs) and/or vasoconstrictors to create a composite formulation. This composite approach extends the duration of effect by enhancing neurotoxin uptake into cells through the synergistic interaction of these components, thereby reducing the need for frequent administrations.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent introduces neurotoxin-associated proteins (NAPs) and/or vasoconstrictors as intermediary substances that facilitate enhanced uptake of the neurotoxin into cells. These intermediaries act as carriers or facilitators that improve the delivery and persistence of the neurotoxin, extending its duration of action.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If higher dosages are administered to extend duration of effect, then the duration improves, but the complexity of administration and potential side effects increase

Engineering Contradiction:
Improveduration of effectVSAvoidadministration complexity
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The patent creates a composite formulation containing botulinum neurotoxin, neurotoxin-associated proteins (NAPs), and/or vasoconstrictors. This composite structure achieves extended duration of effect through enhanced cellular uptake mechanisms, while maintaining a single standardized administration protocol that simplifies the clinical process.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the formulation parameters by incorporating specific ratios of NAPs and/or vasoconstrictors with the neurotoxin. This parameter optimization enhances the duration of effect through improved uptake kinetics, while the formulation remains ready for standard administration procedures, avoiding increased complexity.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If accessory proteins are included to protect the toxin in the stomach, then the toxin stability improves, but the immunogenic response and dissociation in solution increase

Engineering Contradiction:
Improvetoxin stabilityVSAvoidimmunogenic response
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent optimizes the concentration and type of neurotoxin-associated proteins (NAPs) included in the formulation. By carefully controlling these parameters, the patent maintains toxin stability and protection during gastric transit while minimizing immunogenic responses and unwanted dissociation in the target tissue environment.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs different NAPs or combinations of NAPs that provide localized protection. These proteins are designed to stabilize the neurotoxin specifically in the gastric environment during transit, while being engineered to minimize immunogenicity and maintain stability in the target tissue where they are needed.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The enhanced compositions achieve increased efficacy and duration of effect by up to 100% compared to current methods, allowing for lower dosages and less frequent administrations.

Implementation Method 1

enhance the efficacy and duration of effect by increasing the uptake of the neurotoxin into cells

Methodology Applied
Scientific EffectUptake: Absorption (physical)

Data Source

PatentUS20250295740A1Neurotoxin Compositions with Increased Efficacy and Effect Duration
Publication Date: 2025.09.25 EVOLUS INC
  • US20250295740A1 patent drawing
  • US20250295740A1 patent drawing
  • US20250295740A1 patent drawing

AI summary

Disclosed herein are neurotoxin compositions and methods producing an increase in efficacy as well as an extended effect duration.